Literature DB >> 23275908

Angiogenesis-related cytokines in serum of proliferative diabetic retinopathy patients before and after vitrectomy.

Shuang Li1, Xun-An Fu, Xiao-Fang Zhou, You-Yan Chen, Wei-Qun Chen.   

Abstract

AIM: To evaluate serum concentrations of angiogenesis-related cytokines in proliferative diabetic retinopathy (PDR) before and after vitrectomy.
METHODS: Serum samples were collected from 30 PDR patients with varying severity before and after vitrectomy. Serum concentrations of vascular endothelial growth factor (VEGF), pigment epithelium-derived factor (PEDF), interleukin-8 (IL-8) and interferon-inducible protein-10 (IP-10) were determined by enzyme-linked immunosorbent assays (ELISA).
RESULTS: Serum concentrations of VEGF, PEDF, IL-8 and IP-10 were significantly higher in PDR patients than that in controls, respectively (P<0.05). VEGF concentration decreased significantly in postoperative samples than that in preoperative samples (P<0.05). The concentrations of PEDF, IL-8 and IP-10 did not exhibit significant changes after vitrectomy.
CONCLUSION: Elevated cytokines levels in serum may be diagnostically useful in PDR. Angiogenesis-related cytokines play important roles in the development of PDR, and would instruct the risk assessment of pathogenetic condition in PDR patients.

Entities:  

Keywords:  angiogenesis; cytokine; enzyme-linked immunosorbent assay; proliferative diabetic retinopathy; vitrectomy

Year:  2012        PMID: 23275908      PMCID: PMC3530816          DOI: 10.3980/j.issn.2222-3959.2012.06.14

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  24 in total

1.  Interferon-induced protein 10 and interleukin 8. C-X-C chemokines present in proliferative diabetic retinopathy.

Authors:  S G Elner; R Strieter; Z M Bian; S Kunkel; L Mokhtarzaden; M Johnson; N Lukacs; V M Elner
Journal:  Arch Ophthalmol       Date:  1998-12

2.  Loss of the antiangiogenic pigment epithelium-derived factor in patients with angiogenic eye disease.

Authors:  J Spranger; M Osterhoff; M Reimann; M Möhlig; M Ristow; M K Francis; V Cristofalo; H P Hammes; G Smith; M Boulton; A F Pfeiffer
Journal:  Diabetes       Date:  2001-12       Impact factor: 9.461

3.  IFN-gamma-inducible protein-10 attenuates bleomycin-induced pulmonary fibrosis via inhibition of angiogenesis.

Authors:  M P Keane; J A Belperio; D A Arenberg; M D Burdick; Z J Xu; Y Y Xue; R M Strieter
Journal:  J Immunol       Date:  1999-11-15       Impact factor: 5.422

4.  Induction of interleukin-8 preserves the angiogenic response in HIF-1alpha-deficient colon cancer cells.

Authors:  Yusuke Mizukami; Won-Seok Jo; Eva-Maria Duerr; Manish Gala; Jingnan Li; Xiaobo Zhang; Michael A Zimmer; Othon Iliopoulos; Lawrence R Zukerberg; Yutaka Kohgo; Maureen P Lynch; Bo R Rueda; Daniel C Chung
Journal:  Nat Med       Date:  2005-08-28       Impact factor: 53.440

5.  Advanced glycation end products increase retinal vascular endothelial growth factor expression.

Authors:  M Lu; M Kuroki; S Amano; M Tolentino; K Keough; I Kim; R Bucala; A P Adamis
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

6.  Release of the angiogenesis inhibitor angiostatin in patients with proliferative diabetic retinopathy: association with retinal photocoagulation.

Authors:  J Spranger; H P Hammes; K T Preissner; H Schatz; A F Pfeiffer
Journal:  Diabetologia       Date:  2000-11       Impact factor: 10.122

7.  The role of NF-kappaB in retinal neovascularization in the rat. Possible involvement of cytokine-induced neutrophil chemoattractant (CINC), a member of the interleukin-8 family.

Authors:  A Yoshida; S Yoshida; Y Hata; A K Khalil; T Ishibashi; H Inomata
Journal:  J Histochem Cytochem       Date:  1998-04       Impact factor: 2.479

8.  Cytokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.

Authors:  S G Elner; V M Elner; G J Jaffe; A Stuart; S L Kunkel; R M Strieter
Journal:  Curr Eye Res       Date:  1995-11       Impact factor: 2.424

9.  Long-term visual results of vitreous surgery in diabetic eye disease.

Authors:  L Laatikainen; P Summanen
Journal:  Acta Ophthalmol (Copenh)       Date:  1989-02

10.  K469E polymorphism of the intracellular adhesion molecule 1 gene is associated with proliferative diabetic retinopathy in Caucasians with type 2 diabetes.

Authors:  Mojca Globocnik Petrovic; Josko Osredkar; Mirna Saraga-Babić; Daniel Petrovic
Journal:  Clin Exp Ophthalmol       Date:  2008-07       Impact factor: 4.207

View more
  6 in total

Review 1.  Biomarkers in Diabetic Retinopathy.

Authors:  Alicia J Jenkins; Mugdha V Joglekar; Anandwardhan A Hardikar; Anthony C Keech; David N O'Neal; Andrzej S Januszewski
Journal:  Rev Diabet Stud       Date:  2015-08-10

Review 2.  PEDF and its roles in physiological and pathological conditions: implication in diabetic and hypoxia-induced angiogenic diseases.

Authors:  Xuemin He; Rui Cheng; Siribhinya Benyajati; Jian-xing Ma
Journal:  Clin Sci (Lond)       Date:  2015-06       Impact factor: 6.124

3.  Dendrobium chrysotoxum Lindl. alleviates diabetic retinopathy by preventing retinal inflammation and tight junction protein decrease.

Authors:  Zengyang Yu; Chenyuan Gong; Bin Lu; Li Yang; Yuchen Sheng; Lili Ji; Zhengtao Wang
Journal:  J Diabetes Res       Date:  2015-01-01       Impact factor: 4.011

4.  Plasma levels of hypoxia-regulated factors in patients with age-related macular degeneration.

Authors:  Zygoula Ioanna; Schori Christian; Grimm Christian; Barthelmes Daniel
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2017-11-25       Impact factor: 3.117

5.  Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy.

Authors:  Jin-Woo Kwon; Donghyun Jee; Tae Yoon La
Journal:  Medicine (Baltimore)       Date:  2017-03       Impact factor: 1.889

6.  Functional and molecular characterization of ex vivo cultured epiretinal membrane cells from human proliferative diabetic retinopathy.

Authors:  Zoltán Veréb; Xhevat Lumi; Sofija Andjelic; Mojca Globocnik-Petrovic; Mojca Urbancic; Marko Hawlina; Andrea Facskó; Goran Petrovski
Journal:  Biomed Res Int       Date:  2013-10-01       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.